Short Bowel Syndrome Market

Short Bowel Syndrome Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019–2029, Segmented By Type (GLP-2, Growth Hormone, Glutamine); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies); By Region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa)


Global Short Bowel Syndrome Market Size Booming to Cross USD 2 Billion by 2029

Global short bowel syndrome (SBS) market is flourishing because of an increasing demand for SBS drugs due to the high cost of parenteral nutrition and the growing prevalence of short bowel syndrome.

BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated the global short bowel syndrome market size at USD 828.29 million in 2022. During the forecast period between 2023 and 2029, BlueWeave expects the global short bowel syndrome market size to expand at a significant CAGR of 14.05% reaching a value of USD 2,053.24 million by 2029. Major growth drivers for the global short bowel syndrome market include an increasing prevalence of gastrointestinal disorders, advancements in medical technology, and growing awareness among healthcare professionals and patients. The incidence of short bowel syndrome is rising globally, primarily due to factors such as gastrointestinal surgeries, congenital anomalies, inflammatory bowel diseases, and other conditions leading to the removal or dysfunction of a significant portion of the small intestine. This growing prevalence has created a demand for effective treatment options. Advancements in medical technology have played a crucial role in the development of innovative therapies for short bowel syndrome. These advancements encompass parenteral nutrition solutions, intestinal transplantation procedures, and intestinal rehabilitation programs, which have improved patient outcomes and are contributing to market growth. Also, pharmaceutical companies and research organizations are actively investing in research and development efforts to discover and develop new treatment options for short bowel syndrome. These initiatives aim to enhance patients' quality of life and address the existing unmet medical needs in this field. As a result, these factors are expected to drive the expansion of the global short bowel syndrome market throughout the forecast period. However, the high cost of SBS treatment and long-term complications of SBS are anticipated to restrain the overall market growth during the period in analysis.

Global Short Bowel Syndrome Market – Overview


The global Short Bowel Syndrome (SBS) market encompasses the diagnosis, treatment, and management of a condition characterized by the loss or dysfunction of a significant portion of the small intestine. It involves pharmaceutical companies, medical device manufacturers, research organizations, and healthcare providers. Key products and services include pharmacological therapies, parenteral nutrition solutions, medical devices, surgical interventions, rehabilitation programs, and support services. The market is driven by factors such as the rising prevalence of gastrointestinal disorders, advancements in medical technology, research and development investments, and the need for effective SBS management. Market players strive to develop innovative therapies and interventions to improve patient outcomes and quality of life.

Impact of COVID-19 on Global Short Bowel Syndrome Market

COVID-19 pandemic adversely affected the global short bowel syndrome market. The healthcare systems' focus on managing COVID-19 cases, disruptions in the supply chain, and restrictions on non-essential healthcare services have affected the diagnosis, treatment, and management of SBS. Clinical trials for new therapies and medical device development have been delayed or halted, impacting research and development activities. Also, the economic impact of the pandemic has affected healthcare budgets, potentially limiting patients’ access to expensive SBS treatments. However, as the situation improved, the market gradually recovered, supported by increased healthcare investments and a resurgence in research and development efforts.

Global Short Bowel Syndrome Market – By Type

By type, the global short bowel syndrome market is divided into GLP-2, Growth Hormone, and Glutamine segments. The GLP-2 (glucagon-like peptide-2) segment holds the highest share in the global Short Bowel Syndrome (SBS) market due to its effectiveness in managing the condition. GLP-2 is a hormone that plays a crucial role in promoting intestinal growth, enhancing nutrient absorption, and reducing fluid loss. It has shown promising results in clinical trials and is approved for the treatment of SBS in several regions. GLP-2 therapies, such as Teduglutide, have demonstrated the ability to reduce dependence on parenteral nutrition and improve intestinal function. The proven efficacy of GLP-2 treatments has led to their widespread adoption, contributing to the segment's dominant market share in the global SBS market.

Competitive Landscape

Major players operating in the global short bowel syndrome market include Takeda, Emmaus Life Sciences, Nutricia (Danone), Merck KGaA, GlyPharma Therapeutics, Zealand Pharma, Sancilio Pharmaceuticals, Naia Pharmaceuticals, Ardelyx, Adocia, Aralez Pharmaceuticals, Shield Therapeutics, OxThera, Rhythm Pharmaceuticals, and Pivot Pharmaceuticals. To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

The in-depth analysis of the report provides information about growth potential, upcoming trends, and statistics of Global Short Bowel Syndrome Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in Global Short Bowel Syndrome Market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.


1. Research Framework
1.1. Research Objective
1.2. Product Overview
1.3. Market Segmentation
2. Executive Summary
3. Global Short Bowel Syndrome Market Insights
3.1. Industry Value Chain Analysis
3.2. DROC Analysis
3.2.1. Growth Drivers
3.2.1.1. Increasing prevalence of short bowel syndrome
3.2.1.2. Growing demand for SBS drugs due to the high cost of parenteral nutrition
3.2.2. Restraints
3.2.2.1. High cost of SBS treatment
3.2.2.2. Long-term complications of SBS
3.2.3. Opportunities
3.2.3.1. Development of new SBS drugs and therapies
3.2.3.2. Partnerships and collaborations with other companies
3.2.4. Challenges
3.2.4.1. Stringent regulatory requirements
3.2.4.2. Competition from generic drugs
3.3. Technology Advancements/Recent Developments
3.4. Regulatory Framework
3.5. Porter’s Five Forces Analysis
3.5.1. Bargaining Power of Suppliers
3.5.2. Bargaining Power of Buyers
3.5.3. Threat of New Entrants
3.5.4. Threat of Substitutes
3.5.5. Intensity of Rivalry
4. Global Short Bowel Syndrome Market Overview
4.1. Market Size & Forecast, 2019–2029
4.1.1. By Value (USD Million)
4.2. Market Share and Forecast
4.2.1. By Type
4.2.1.1. GLP-2
4.2.1.2. Growth Hormone
4.2.1.3. Glutamine
4.2.1.4. Others
4.2.2. By Distribution Channel
4.2.2.1. Hospital Pharmacies
4.2.2.2. Retail Pharmacies
4.2.2.3. Others
4.2.3. By Region
4.2.3.1. North America
4.2.3.2. Europe
4.2.3.3. Asia Pacific (APAC)
4.2.3.4. Latin America (LATAM)
4.2.3.5. Middle East and Africa (MEA)
5. North America Short Bowel Syndrome Market
5.1. Market Size & Forecast, 2019–2029
5.1.1. By Value (USD Million)
5.2. Market Share & Forecast
5.2.1. By Type
5.2.2. By Distribution Channel
5.2.3. By Country
5.2.3.1. United States
5.2.3.1.1. By Type
5.2.3.1.2. By Distribution Channel
5.2.3.2. Canada
5.2.3.2.1. By Type
5.2.3.2.2. By Distribution Channel
6. Europe Short Bowel Syndrome Market
6.1. Market Size & Forecast, 2019–2029
6.1.1. By Value (USD Million)
6.2. Market Share & Forecast
6.2.1. By Type
6.2.2. By Distribution Channel
6.2.3. By Country
6.2.3.1. Germany
6.2.3.1.1. By Type
6.2.3.1.2. By Distribution Channel
6.2.3.2. United Kingdom
6.2.3.2.1. By Type
6.2.3.2.2. By Distribution Channel
6.2.3.3. Italy
6.2.3.3.1. By Type
6.2.3.3.2. By Distribution Channel
6.2.3.4. France
6.2.3.4.1. By Type
6.2.3.4.2. By Distribution Channel
6.2.3.5. Spain
6.2.3.5.1. By Type
6.2.3.5.2. By Distribution Channel
6.2.3.6. Belgium
6.2.3.6.1. By Type
6.2.3.6.2. By Distribution Channel
6.2.3.7. Russia
6.2.3.7.1. By Type
6.2.3.7.2. By Distribution Channel
6.2.3.8. Rest of Europe
6.2.3.8.1. By Type
6.2.3.8.2. By Distribution Channel
7. Asia Pacific Short Bowel Syndrome Market
7.1. Market Size & Forecast, 2019–2029
7.1.1. By Value (USD Million)
7.2. Market Share & Forecast
7.2.1. By Type
7.2.2. By Distribution Channel
7.2.3. By Country
7.2.3.1. China
7.2.3.1.1. By Type
7.2.3.1.2. By Distribution Channel
7.2.3.2. India
7.2.3.2.1. By Type
7.2.3.2.2. By Distribution Channel
7.2.3.3. Japan
7.2.3.3.1. By Type
7.2.3.3.2. By Distribution Channel
7.2.3.4. South Korea
7.2.3.4.1. By Type
7.2.3.4.2. By Distribution Channel
7.2.3.5. Australia & New Zealand
7.2.3.5.1. By Type
7.2.3.5.2. By Distribution Channel
7.2.3.6. Indonesia
7.2.3.6.1. By Type
7.2.3.6.2. By Distribution Channel
7.2.3.7. Malaysia
7.2.3.7.1. By Type
7.2.3.7.2. By Distribution Channel
7.2.3.8. Singapore
7.2.3.8.1. By Type
7.2.3.8.2. By Distribution Channel
7.2.3.9. Vietnam
7.2.3.9.1. By Type
7.2.3.9.2. By Distribution Channel
7.2.3.10. Rest of APAC
7.2.3.10.1. By Type
7.2.3.10.2. By Distribution Channel
8. Latin America Short Bowel Syndrome Market
8.1. Market Size & Forecast, 2019–2029
8.1.1. By Value (USD Million)
8.2. Market Share & Forecast
8.2.1. By Type
8.2.2. By Distribution Channel
8.2.3. By Country
8.2.3.1. Brazil
8.2.3.1.1. By Type
8.2.3.1.2. By Distribution Channel
8.2.3.2. Mexico
8.2.3.2.1. By Type
8.2.3.2.2. By Distribution Channel
8.2.3.3. Argentina
8.2.3.3.1. By Type
8.2.3.3.2. By Distribution Channel
8.2.3.4. Peru
8.2.3.4.1. By Type
8.2.3.4.2. By Distribution Channel
8.2.3.5. Rest of LATAM
8.2.3.5.1. By Type
8.2.3.5.2. By Distribution Channel
9. Middle East & Africa Short Bowel Syndrome Market
9.1. Market Size & Forecast, 2019–2029
9.1.1. By Value (USD Million)
9.2. Market Share & Forecast
9.2.1. By Type
9.2.2. By Distribution Channel
9.2.3. By Country
9.2.3.1. Saudi Arabia
9.2.3.1.1. By Type
9.2.3.1.2. By Distribution Channel
9.2.3.2. UAE
9.2.3.2.1. By Type
9.2.3.2.2. By Distribution Channel
9.2.3.3. Qatar
9.2.3.3.1. By Type
9.2.3.3.2. By Distribution Channel
9.2.3.4. Kuwait
9.2.3.4.1. By Type
9.2.3.4.2. By Distribution Channel
9.2.3.5. South Africa
9.2.3.5.1. By Type
9.2.3.5.2. By Distribution Channel
9.2.3.6. Nigeria
9.2.3.6.1. By Type
9.2.3.6.2. By Distribution Channel
9.2.3.7. Algeria
9.2.3.7.1. By Type
9.2.3.7.2. By Distribution Channel
9.2.3.8. Rest of MEA
9.2.3.8.1. By Type
9.2.3.8.2. By Distribution Channel
10. Competitive Landscape
10.1. List of Key Players and Their Offerings
10.2. Global Short Bowel Syndrome Market Share Analysis, 2022
10.3. Competitive Benchmarking, By Operating Parameters
10.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)
11. Impact of Covid-19 on Global Short Bowel Syndrome Market
12. Company Profile (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, SWOT Analysis)
12.1. Takeda
12.2. Emmaus Life Sciences
12.3. Nutricia (Danone)
12.4. Merck KGaA
12.5. GlyPharma Therapeutics
12.6. Zealand Pharma
12.7. Sancilio Pharmaceuticals
12.8. Naia Pharmaceuticals
12.9. Ardelyx
12.10. Adocia
12.11. Aralez Pharmaceuticals
12.12. Shield Therapeutics
12.13. OxThera
12.14. Rhythm Pharmaceuticals
12.15. Pivot Pharmaceuticals
12.16. Other Prominent Players
13. Key Strategic Recommendations
14. Research Methodology
14.1. Qualitative Research
14.1.1. Primary & Secondary Research
14.2. Quantitative Research
14.3. Market Breakdown & Data Triangulation
14.3.1. Secondary Research
14.3.2. Primary Research
14.4. Breakdown of Primary Research Respondents, By Region
14.5. Assumptions & Limitations
*Financial information of case of non-listed companies can be provided as per availability.
**The segmentation and the companies are subject to modifications based on in-depth secondary research for the final deliverable
Figures
Figure 1 Global Short Bowel Syndrome Market Segmentation
Figure 2 Global Short Bowel Syndrome Market Value Chain Analysis
Figure 3 Company Market Share Analysis, 2022
Figure 4 Global Short Bowel Syndrome Market Size, By Value (USD Billion), 2019−2029
Figure 5 Global Short Bowel Syndrome Market Share, By Type, By Value, 2019−2029
Figure 6 Global Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019−2029
Figure 7 Global Short Bowel Syndrome Market Share, By Region, By Value, 2019−2029
Figure 8 North America Short Bowel Syndrome Market Size, By Value (USD Billion), 2019−2029
Figure 9 North America Short Bowel Syndrome Market Share, By Type, By Value, 2019−2029
Figure 10 North America Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019−2029
Figure 11 North America Short Bowel Syndrome Market Share, By Country, By Value, 2019−2029
Figure 12 United States Short Bowel Syndrome Market Size, By Value (USD Billion), 2019−2029
Figure 13 United States Short Bowel Syndrome Market Share, By Type, By Value, 2019−2029
Figure 14 United States Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019−2029
Figure 15 Canada Short Bowel Syndrome Market Size, By Value (USD Billion), 2019−2029
Figure 16 Canada Short Bowel Syndrome Market Share, By Type, By Value, 2019−2029
Figure 17 Canada Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019−2029
Figure 18 Europe Short Bowel Syndrome Market Size, By Value (USD Billion), 2019−2029
Figure 19 Europe Short Bowel Syndrome Market Share, By Type, By Value, 2019−2029
Figure 20 Europe Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019−2029
Figure 21 Europe Short Bowel Syndrome Market Share, By Country, By Value, 2019−2029
Figure 22 Germany Short Bowel Syndrome Market Size, By Value (USD Billion), 2019−2029
Figure 23 Germany Short Bowel Syndrome Market Share, By Type, By Value, 2019−2029
Figure 24 Germany Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019−2029
Figure 25 United Kingdom Short Bowel Syndrome Market Size, By Value (USD Billion), 2019−2029
Figure 26 United Kingdom Short Bowel Syndrome Market Share, By Type, By Value, 2019−2029
Figure 27 United Kingdom Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019−2029
Figure 28 Italy Short Bowel Syndrome Market Size, By Value (USD Billion), 2019−2029
Figure 29 Italy Short Bowel Syndrome Market Share, By Type, By Value, 2019−2029
Figure 30 Italy Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019−2029
Figure 31 France Short Bowel Syndrome Market Size, By Value (USD Billion), 2019−2029
Figure 32 France Short Bowel Syndrome Market Share, By Type, By Value, 2019−2029
Figure 33 France Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019−2029
Figure 34 Spain Short Bowel Syndrome Market Size, By Value (USD Billion), 2019−2029
Figure 35 Spain Short Bowel Syndrome Market Share, By Type, By Value, 2019−2029
Figure 36 Spain Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019−2029
Figure 37 Belgium Short Bowel Syndrome Market Size, By Value (USD Billion), 2019−2029
Figure 38 Belgium Short Bowel Syndrome Market Share, By Type, By Value, 2019−2029
Figure 39 Belgium Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019−2029
Figure 40 Rest of Europe Short Bowel Syndrome Market Size, By Value (USD Billion), 2019−2029
Figure 41 Rest of Europe Short Bowel Syndrome Market Share, By Technology, By Value, 2019−2029
Figure 42 Rest of Europe Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019−2029
Figure 43 The Asia-Pacific Short Bowel Syndrome Market Size, By Value (USD Billion), 2019−2029
Figure 44 The Asia-Pacific Short Bowel Syndrome Market Share, By Type, By Value, 2019−2029
Figure 45 The Asia-Pacific Short Bowel Syndrome Market Share, By Deployment, By Value, 2019−2029
Figure 46 The Asia-Pacific Short Bowel Syndrome Market Share, By Country, By Value, 2019−2029
Figure 47 China Short Bowel Syndrome Market Size, By Value (USD Billion), 2019−2029
Figure 48 China Short Bowel Syndrome Market Share, By Type, By Value, 2019−2029
Figure 49 China Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019−2029
Figure 50 India Short Bowel Syndrome Market Size, By Value (USD Billion), 2019−2029
Figure 51 India Short Bowel Syndrome Market Share, By Type, By Value, 2019−2029
Figure 52 India Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019−2029
Figure 53 Japan Short Bowel Syndrome Market Size, By Value (USD Billion), 2019−2029
Figure 54 Japan Short Bowel Syndrome Market Share, By Type, By Value, 2019−2029
Figure 55 Japan Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019−2029
Figure 56 South Korea Short Bowel Syndrome Market Size, By Value (USD Billion), 2019−2029
Figure 57 South Korea Short Bowel Syndrome Market Share, By Type, By Value, 2019−2029
Figure 58 South Korea Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019−2029
Figure 59 Australia & New Zealand Short Bowel Syndrome Market Size, By Value (USD Billion), 2019−2029
Figure 60 Australia & New Zealand Short Bowel Syndrome Market Share, By Type, By Value, 2019−2029
Figure 61 Australia & New Zealand Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019−2029
Figure 62 Indonesia Short Bowel Syndrome Market Size, By Value (USD Billion), 2019−2029
Figure 63 Indonesia Short Bowel Syndrome Market Share, By Type, By Value, 2019−2029
Figure 64 Indonesia Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019−2029
Figure 65 Malaysia Short Bowel Syndrome Market Size, By Value (USD Billion), 2019−2029
Figure 66 Malaysia Short Bowel Syndrome Market Share, By Type, By Value, 2019−2029
Figure 67 Malaysia Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019−2029
Figure 68 Singapore Short Bowel Syndrome Market Size, By Value (USD Billion), 2019−2029
Figure 69 Singapore Short Bowel Syndrome Market Share, By Type, By Value, 2019−2029
Figure 70 Singapore Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019−2029
Figure 71 Vietnam Short Bowel Syndrome Market Size, By Value (USD Billion), 2019−2029
Figure 72 Vietnam Short Bowel Syndrome Market Share, By Type, By Value, 2019−2029
Figure 73 Vietnam Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019−2029
Figure 74 Rest of Asia Pacific Short Bowel Syndrome Market Size, By Value (USD Billion), 2019−2029
Figure 75 Rest of Asia Pacific Short Bowel Syndrome Market Share, By Type, By Value, 2019−2029
Figure 76 Rest of Asia Pacific Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019−2029
Figure 77 Latin America Short Bowel Syndrome Market Size, By Value (USD Billion), 2019−2029
Figure 78 Latin America Short Bowel Syndrome Market Share, By Type, By Value, 2019−2029
Figure 79 Latin America Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019−2029
Figure 80 Latin America Short Bowel Syndrome Market Share, By Country, By Value, 2019−2029
Figure 81 Brazil Short Bowel Syndrome Market Size, By Value (USD Billion), 2019−2029
Figure 82 Brazil Short Bowel Syndrome Market Share, By Type, By Value, 2019−2029
Figure 83 Brazil Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019−2029
Figure 84 Mexico Short Bowel Syndrome Market Size, By Value (USD Billion), 2019−2029
Figure 85 Mexico Short Bowel Syndrome Market Share, By Type, By Value, 2019−2029
Figure 86 Mexico Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019−2029
Figure 87 Argentina Short Bowel Syndrome Market Size, By Value (USD Billion), 2019−2029
Figure 88 Argentina Short Bowel Syndrome Market Share, By Type, By Value, 2019−2029
Figure 89 Argentina Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019−2029
Figure 90 Peru Short Bowel Syndrome Market Size, By Value (USD Billion), 2019−2029
Figure 91 Peru Short Bowel Syndrome Market Share, By Type, By Value, 2019−2029
Figure 92 Peru Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019−2029
Figure 93 Rest of Latin America Short Bowel Syndrome Market Size, By Value (USD Billion), 2019−2029
Figure 94 Rest of Latin America Short Bowel Syndrome Market Share, By Type By Value, 2019−2029
Figure 95 Rest of Latin America Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019−2029
Figure 96 The Middle East & Africa Short Bowel Syndrome Market Size, By Value (USD Billion), 2019−2029
Figure 97 The Middle East & Africa Short Bowel Syndrome Market Share, By Type, By Value, 2019−2029
Figure 98 The Middle East & Africa Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019−2029
Figure 99 The Middle East & Africa Short Bowel Syndrome Market Share, By Country, By Value, 2019−2029
Figure 100 Saudi Arabia Short Bowel Syndrome Market Size, By Value (USD Billion), 2019−2029
Figure 101 Saudi Arabia Short Bowel Syndrome Market Share, By Type, By Value, 2019−2029
Figure 102 Saudi Arabia Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019−2029
Figure 103 UAE Short Bowel Syndrome Market Size, By Value (USD Billion), 2019−2029
Figure 104 UAE Short Bowel Syndrome Market Share, By Type, By Value, 2019−2029
Figure 105 UAE Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019−2029
Figure 106 Qatar Short Bowel Syndrome Market Size, By Value (USD Billion), 2019−2029
Figure 107 Qatar Short Bowel Syndrome Market Share, By Type, By Value, 2019−2029
Figure 108 Qatar Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019−2029
Figure 109 Kuwait Short Bowel Syndrome Market Size, By Value (USD Billion), 2019−2029
Figure 110 Kuwait Short Bowel Syndrome Market Share, By Type, By Value, 2019−2029
Figure 111 Kuwait Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019−2029
Figure 112 Iran Short Bowel Syndrome Market Size, By Value (USD Billion), 2019−2029
Figure 113 Iran Short Bowel Syndrome Market Share, By Type, By Value, 2019−2029
Figure 114 Iran Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019−2029
Figure 115 South Africa Short Bowel Syndrome Market Size, By Value (USD Billion), 2019−2029
Figure 116 South Africa Short Bowel Syndrome Market Share, By Type, By Value, 2019−2029
Figure 117 South Africa Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019−2029
Figure 118 Nigeria Short Bowel Syndrome Market Size, By Value (USD Billion), 2019−2029
Figure 119 Nigeria Short Bowel Syndrome Market Share, By Type, By Value, 2019−2029
Figure 120 Nigeria Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019−2029
Figure 121 Kenya Short Bowel Syndrome Market Size, By Value (USD Billion), 2019−2029
Figure 122 Kenya Short Bowel Syndrome Market Share, By Type, By Value, 2019−2029
Figure 123 Kenya Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019−2029
Figure 124 Egypt Short Bowel Syndrome Market Size, By Value (USD Billion), 2019−2029
Figure 125 Egypt Short Bowel Syndrome Market Share, By Type, By Value, 2019−2029
Figure 126 Egypt Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019−2029
Figure 127 Morocco Short Bowel Syndrome Market Size, By Value (USD Billion), 2019−2029
Figure 128 Morocco Short Bowel Syndrome Market Share, By Type, By Value, 2019−2029
Figure 129 Morocco Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019−2029
Figure 130 Algeria Short Bowel Syndrome Market Size, By Value (USD Billion), 2019−2029
Figure 131 Algeria Short Bowel Syndrome Market Share, By Type, By Value, 2019−2029
Figure 132 Algeria Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019−2029
Figure 133 Rest of Middle East & Africa Short Bowel Syndrome Market Size, By Value (USD Billion), 2019−2029
Figure 134 Rest of Middle East & Africa Short Bowel Syndrome Market Share, By Type, By Value, 2019−2029
Figure 135 Rest of Middle East & Africa Short Bowel Syndrome Market Share, By Distribution Channel, By Value, 2019−2029
Tables
Table 1 Global Short Bowel Syndrome Market Size, By Type, By Value, 2019−2029
Table 2 Global Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019−2029
Table 3 Global Short Bowel Syndrome Market Size, By Region, By Value, 2019−2029
Table 4 North America Short Bowel Syndrome Market Size, By Type, By Value, 2019−2029
Table 5 North America Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019−2029
Table 6 North America Short Bowel Syndrome Market Size, By Country, By Value, 2019−2029
Table 7 United States Short Bowel Syndrome Market Size, By Type, By Value, 2019−2029
Table 8 United States Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019−2029
Table 9 Canada Short Bowel Syndrome Market Size, By Type, By Value, 2019−2029
Table 10 Canada Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019−2029
Table 11 Europe Short Bowel Syndrome Market Size, By Type, By Value, 2019−2029
Table 12 Europe Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019−2029
Table 13 Europe Short Bowel Syndrome Market Size, By Country, By Value, 2019−2029
Table 14 Germany Short Bowel Syndrome Market Size, By Type, By Value, 2019−2029
Table 15 Germany Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019−2029
Table 16 United Kingdom Short Bowel Syndrome Market Size, By Type, By Value, 2019−2029
Table 17 United Kingdom Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019−2029
Table 18 Italy Short Bowel Syndrome Market Size, By Type, By Value, 2019−2029
Table 19 Italy Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019−2029
Table 20 France Short Bowel Syndrome Market Size, By Type, By Value, 2019−2029
Table 21 France Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019−2029
Table 22 Spain Short Bowel Syndrome Market Size, By Type, By Value, 2019−2029
Table 23 Spain Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019−2029
Table 24 Belgium Short Bowel Syndrome Market Size, By Type, By Value, 2019−2029
Table 25 Belgium Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019−2029
Table 26 Rest of Europe Short Bowel Syndrome Market Size, By Type, By Value, 2019−2029
Table 27 Rest of Europe Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019−2029
Table 28 The Asia-Pacific Short Bowel Syndrome Market Size, By Type, By Value, 2019−2029
Table 29 The Asia-Pacific Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019−2029
Table 30 The Asia-Pacific Short Bowel Syndrome Market Size, By Country, By Value, 2019−2029
Table 31 China Short Bowel Syndrome Market Size, By Type, By Value, 2019−2029
Table 32 China Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019−2029
Table 33 India Short Bowel Syndrome Market Size, By Type, By Value, 2019−2029
Table 34 India Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019−2029
Table 35 Japan Short Bowel Syndrome Market Size, By Type, By Value, 2019−2029
Table 36 Japan Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019−2029
Table 37 South Korea Short Bowel Syndrome Market Size, By Type, By Value, 2019−2029
Table 38 South Korea Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019−2029
Table 39 Australia & New Zealand Short Bowel Syndrome Market Size, By Type, By Value, 2019−2029
Table 40 Australia & New Zealand Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019−2029
Table 41 Indonesia Short Bowel Syndrome Market Size, By Type, By Value, 2019−2029
Table 42 Indonesia Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019−2029
Table 43 Malaysia Short Bowel Syndrome Market Size, By Type, By Value, 2019−2029
Table 44 Malaysia Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019−2029
Table 45 Singapore Short Bowel Syndrome Market Size, By Type, By Value, 2019−2029
Table 46 Singapore Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019−2029
Table 47 Philippines Short Bowel Syndrome Market Size, By Type, By Value, 2019−2029
Table 48 Philippines Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019−2029
Table 49 Vietnam Short Bowel Syndrome Market Size, By Type, By Value, 2019−2029
Table 50 Vietnam Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019−2029
Table 51 Rest of Asia Pacific Short Bowel Syndrome Market Size, By Type, By Value, 2019−2029
Table 52 Rest of Asia Pacific Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019−2029
Table 53 Latin America Short Bowel Syndrome Market Size, By Type, By Value, 2019−2029
Table 54 Latin America Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019−2029
Table 55 Latin America Short Bowel Syndrome Market Size, By Country, By Value, 2019−2029
Table 56 Brazil Short Bowel Syndrome Market Size, By Type, By Value, 2019−2029
Table 57 Brazil Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019−2029
Table 58 Mexico Short Bowel Syndrome Market Size, By Type, By Value, 2019−2029
Table 59 Mexico Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019−2029
Table 60 Argentina Short Bowel Syndrome Market Size, By Type, By Value, 2019−2029
Table 61 Argentina Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019−2029
Table 62 Peru Short Bowel Syndrome Market Size, By Type, By Value, 2019−2029
Table 63 Peru Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019−2029
Table 64 Rest of Latin America Short Bowel Syndrome Market Size, By Type, By Value, 2019−2029
Table 65 Rest of Latin America Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019−2029
Table 66 The Middle East & Africa Short Bowel Syndrome Market Size, By Type, By Value, 2019−2029
Table 67 The Middle East & Africa Short Bowel Syndrome Market Size, By Country, By Value, 2019−2029
Table 68 Saudi Arabia Short Bowel Syndrome Market Size, By Type, By Value, 2019−2029
Table 69 Saudi Arabia Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019−2029
Table 70 UAE Short Bowel Syndrome Market Size, By Type, By Value, 2019−2029
Table 71 UAE Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019−2029
Table 72 Qatar Short Bowel Syndrome Market Size, By Type, By Value, 2019−2029
Table 73 Qatar Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019−2029
Table 74 Kuwait Short Bowel Syndrome Market Size, By Type, By Value, 2019−2029
Table 75 Kuwait Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019−2029
Table 76 Iran Short Bowel Syndrome Market Size, By Type, By Value, 2019−2029
Table 77 Iran Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019−2029
Table 78 South Africa Short Bowel Syndrome Market Size, By Type, By Value, 2019−2029
Table 79 South Africa Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019−2029
Table 80 Nigeria Short Bowel Syndrome Market Size, By Type, By Value, 2019−2029
Table 81 Nigeria Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019−2029
Table 82 Kenya Short Bowel Syndrome Market Size, By Type, By Value, 2019−2029
Table 83 Kenya Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019−2029
Table 84 Egypt Short Bowel Syndrome Market Size, By Type, By Value, 2019−2029
Table 85 Egypt Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019−2029
Table 86 Morocco Short Bowel Syndrome Market Size, By Type, By Value, 2019−2029
Table 87 Morocco Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019−2029
Table 88 Algeria Short Bowel Syndrome Market Size, By Type, By Value, 2019−2029
Table 89 Algeria Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019−2029
Table 90 Rest of Middle East & Africa Short Bowel Syndrome Market Size, By Type, By Value, 2019−2029
Table 91 Rest of Middle East & Africa Short Bowel Syndrome Market Size, By Distribution Channel, By Value, 2019−2029
Table 92 Takeda Company Overview
Table 93 Takeda Financial Overview
Table 94 Emmaus Life Sciences Company Overview
Table 95 Emmaus Life Sciences Financial Overview
Table 96 Nutricia (Danone) Company Overview
Table 97 Nutricia (Danone) Financial Overview
Table 98 Merck KGaA Company Overview
Table 99 Merck KGaA Financial Overview
Table 100 GlyPharma Therapeutics Company Overview
Table 101 GlyPharma Therapeutics Financial Overview
Table 102 Zealand Pharma Company Overview
Table 103 Zealand Pharma Financial Overview
Table 104 Sancilio Pharmaceuticals Company Overview
Table 105 Sancilio Pharmaceuticals Financial Overview
Table 106 Naia Pharmaceuticals Company Overview
Table 107 Naia Pharmaceuticals Financial Overview
Table 108 Ardelyx Company Overview
Table 109 Ardelyx Financial Overview
Table 110 Adocia Company Overview
Table 111 Adocia Financial Overview
Table 112 Aralez Pharmaceuticals Company Overview
Table 113 Aralez Pharmaceuticals Financial Overview
Table 114 Pivot Pharmaceuticals Company Overview
Table 115 Pivot Pharmaceuticals Financial Overview
Table 116 Other Prominent Players Company Overview
Table 117 Other Prominent Players Financial Overview

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings